Topical corticosteroid (TC) abuse is a common, worldwide, problem. One of the recent emerging concerns is the adulteration of TC in fairness cream. The presence of TC in skin-whitening cosmetic creams can be detected by high-performance liquid chromatography (HPLC). Since HPLC is expensive, time-taking and not easily available, we suggest the use of histamine wheal test as a simple and inexpensive test to detect the presence of topical steroids in fairness cream.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11152470 | PMC |
| http://dx.doi.org/10.4103/idoj.idoj_321_23 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comparing the effectiveness of four antihistamines with olopatadine in healthy Thoroughbred horses.
J Vet Med Sci
January 2025
Equine Research Institute, Japan Racing Association.
We compared the antihistamine effect of four new antihistamines with olopatadine, which is used to treat equine allergic diseases. Six healthy Thoroughbred horses received oral doses of olopatadine (50 mg), levocetirizine (50 mg), bilastine (200 mg), rupatadine (100 mg), and desloratadine (50 mg) at >2-week intervals. The effects were investigated by measurement of the wheal area induced by histamine intradermal injection, and inhibition rate was compared with positive and negative controls.
View Article and Find Full Text PDFBilastine Reimagined: A Comprehensive Exploration of Pruritus Management With a Novel Antihistamine.
Cureus
October 2024
Medical Affairs, Alkem Laboratories Ltd., Mumbai, IND.
Managing pruritic conditions is essential due to their significant impact on patients' quality of life. Chronic urticaria (CU), characterized by persistent itching and hives, severely affects daily activities and sleep. CU includes chronic inducible urticaria and chronic spontaneous urticaria, with the latter lacking identifiable triggers, making treatment especially challenging.
View Article and Find Full Text PDFEquivalence in intradermal reactions to histamine and compound 48/80 in dogs before and after sedation with dexmedetomidine or a 1:20 combination of medetomidine and vatinoxan.
Vet Dermatol
February 2025
Department of Comparative, Diagnostic and Population Medicine College of Veterinary Medicine, University of Florida, Gainesville, Florida, USA.
Background: Intradermal allergen testing (IDAT) is commonly used to formulate allergen-specific immunotherapy, a pillar treatment for canine atopic dermatitis. Many sedatives have shown histaminergic or anti-histaminergic effects and thus been deemed unsuitable for IDAT.
Objective: The goal of this study was to determine whether, in healthy dogs, dexmedetomidine (Dexdomitor) or a 1:20 combination of medetomidine and vatinoxan (Zenalpha) will affect intradermal reactions compared to unsedated dogs.
Chronic Spontaneous Urticaria: A Review.
JAMA
November 2024
Urticaria Center of Reference and Excellence (UCARE), Institute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Article Synopsis
- * Diagnosis is usually made based on recurring symptoms like wheals and angioedema, and it often lasts over a year; around 40% of patients experience significant negative effects on their quality of life.
- * First-line treatment includes second-generation H1 antihistamines, with about 40% of patients showing improvement, while omalizumab is recommended for those not responding to antihistamines, although 30% may not benefit; cyclosporine is another option with some effectiveness but potential side
Comparative inhibition by oral bilastine, parenteral dexchlorpheniramine, and a new bilastine parenteral (i.v. and i.m.) formulation of histamine-induced wheal and flare response: A randomised phase I trial.
Eur J Pharm Sci
December 2024
Medical Department, FAES FARMA S. A., Leioa (Vizcaya), Spain. Electronic address:
Article Synopsis
- Bilastine is a non-sedating antihistamine effective for treating allergies, and this study aimed to compare its different formulations (i.v., i.m., and oral) against dexchlorpheniramine and placebo for their antihistamine activity and onset time.
- Conducted on 25 healthy adults, the study demonstrated that all bilastine formulations provided quick relief (15 min for i.v. and i.m., 30 min for oral) and significantly reduced allergic reactions compared to dexchlorpheniramine and placebo.
- The results showed that bilastine formulations were not only more effective but also safe, with no serious adverse events reported, while dexchlorpheniramine was
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!